Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Fakhar Siddiqui"'
Autor:
James A. Karlowsky, Mark G. Wise, Tai-Chin Hsieh, Hung-Chi Lu, Wei-Ting Chen, Ming-Huei Cheng, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 34, Iss , Pp 106-112 (2023)
ABSTRACT: Objectives: To determine the in vitro activities of ceftolozane/tazobactam (C/T) and comparators against Pseudomonas aeruginosa isolates cultured from hospitalised patient samples in Taiwan from 2012 to 2021 with an additional focus on the
Externí odkaz:
https://doaj.org/article/3e5e47fbc6ff4a82ae065a886c5d8f5b
Autor:
Amanda Azevedo Bittencourt, Gustavo Mizuno, Marina Della Negra de Paula, Charles Andrew DeRyke, Fakhar Siddiqui, Vinicius Lima Faustino, Paula de Mendonça Batista, Thales José Bueno Polis
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss , Pp 102877- (2023)
Introdução: Pseudomonas aeruginosa com resistência a carbapenêmicos é um patógeno considerado prioritário (nível crítico) pela Organização Mundial da Saúde para o desenvolvimento de novos antimicrobianos. A resistência a antimicrobianos
Externí odkaz:
https://doaj.org/article/48798fe5f1f44e02a7aba4beefe55f25
Autor:
Sibylle H. Lob, Mark A. Estabrook, C. Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Publikováno v:
International Journal of Infectious Diseases, Vol 125, Iss , Pp 250-257 (2022)
Objectives: We evaluated the activity of ceftolozane/tazobactam (C/T), and comparators against clinical Pseudomonas aeruginosa isolates collected for the global Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance program in ten
Externí odkaz:
https://doaj.org/article/0f3e5fee3733454da0f7846a3cd6b3de
Autor:
Sibylle H. Lob, Krystyna M. Kazmierczak, Wei-Ting Chen, Fakhar Siddiqui, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 527-533 (2022)
Objectives: Antimicrobial resistance is one of the top 10 global public-health threats. Especially high rates of resistance have been reported for isolates from ICU patients, requiring expanded treatment options in this setting. We evaluated the acti
Externí odkaz:
https://doaj.org/article/4a683a0e7cbc4207acf33beb6204a569
Autor:
James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Jacqueline Pavia, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 3, Pp 102775- (2023)
Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa are being isolated from patient specimens with increasing frequency in Latin America and worldwide. The current study provides an initial description of the in vitro activity of imipene
Externí odkaz:
https://doaj.org/article/a0da972580054cb2a31020aeecfd37f4
Autor:
Sibylle H. Lob, Stephen P. Hawser, Fakhar Siddiqui, Irina Alekseeva, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 42:365-370
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4acfe200f46a99606c422c32e4c75d1f
https://doi.org/10.1007/s10096-023-04549-1
https://doi.org/10.1007/s10096-023-04549-1
Autor:
James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Brune Akrich, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Stephen P. Hawser, Daniel F. Sahm
Publikováno v:
Journal of Medical Microbiology. 72
Introduction. Piperacillin/tazobactam and carbapenems are important agents for the treatment of serious Gram-negative infections in hospitalized patients. Resistance to both agents is a significant concern in clinical isolates of Enterobacterales and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::931797a0af11a71f41415b955281fb98
https://doi.org/10.1099/jmm.0.001645
https://doi.org/10.1099/jmm.0.001645
Autor:
Sibylle Lob, Meredith Hackel, Fakhar Siddiqui, Karri A Bauer, Charles A DeRyke, Katherine Young, Mary Motyl, Daniel F Sahm
Publikováno v:
Open Forum Infectious Diseases. 9
Background Antimicrobial resistance of P. aeruginosa to commonly used β-lactams is typically higher in isolates collected from ICU patients and those with hospital-acquired infections. P. aeruginosa with multidrug-resistance (MDR) or difficult-to-tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3122e0eceacb22457bd35f700c7005
https://doi.org/10.1093/ofid/ofac492.1300
https://doi.org/10.1093/ofid/ofac492.1300
Publikováno v:
Open Forum Infectious Diseases. 9
Background Clostridioides difficile infection (CDI) is one of the most frequently reported healthcare-associated infections in the US with almost half a million cases reported annually. The most recent IDSA guidelines recommend use of bezlotoxumab (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89504cfb317b25f198c17a30e61c982f
https://doi.org/10.1093/ofid/ofac492.457
https://doi.org/10.1093/ofid/ofac492.457
Autor:
Sibylle Lob, Meredith Hackel, Fakhar Siddiqui, Karri A Bauer, Charles A DeRyke, Katherine Young, Mary Motyl, Daniel F Sahm
Publikováno v:
Open Forum Infectious Diseases. 9
Background Gram-negative pathogens with multidrug resistance (MDR) or difficult-to-treat resistance (DTR) are increasingly common, resulting in limited treatment options. These resistant pathogens are often isolated from the respiratory tract or bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b1bc2d33443c0f9c5449af3ad34422
https://doi.org/10.1093/ofid/ofac492.1301
https://doi.org/10.1093/ofid/ofac492.1301